Determining INdividual Preferences for Gynecomastia avOidance (DINGO) - Stage 1
Recruiting
N/A
Interventional Study
Prostate Cancer (Adenocarcinoma)
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Male
- Study type
- Interventional
- Purpose
- Supportive Care
- Participants needed
- 24 (estimated)
- Sponsor
- St Vincent's Hospital, Sydney · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This study aims to explore the perceptions of men with prostate cancer (PCa) and high-risk biochemical recurrence (BCR) regarding the risk of breast-related side effects, including gynaecomastia, from treatment.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Men with high-risk BCR PCa but no ADT+/-ARPI experience.
* Men with ADT+/-ARPI experience who have experienced breast-related side effects from this treatment.
Exclusion Criteria:
• Men receiving psychiatric care as a consequence of their prostate cancer diagnosis or treatme…
Contacts
No contact information available.